Teligent Pharma, Inc. is recalling 3,432 tubes of Flurandrenolide Ointment USP, 0.05% (60-gram tubes) because the product failed to meet stability testing requirements for impurities and degradation. This means the medication may contain higher-than-allowed levels of breakdown products, which could affect the safety or effectiveness of the ointment. This prescription medication is used to treat various skin conditions and was distributed nationwide. If you have this medication, you should contact your healthcare provider or pharmacist for guidance and return any unused product to the pharmacy for a refund.
The product failed testing specifications for impurities and degradation, which could potentially lead to reduced effectiveness of the treatment or unexpected side effects from the degraded chemical components.
Pharmacy refund and healthcare consultation
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.